Tag: Lilly
Eli Lilly CEO expects new weight loss pill to be approved next year
David Ricks, CEO, Eli LillyScott Mlyn | CNBCEli Lilly expects its experimental weight loss pill will get approved as soon as early next year, CEO Davi [...]
Eli Lilly weight loss drug Zepbound no longer in shortage
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023.Brendan McDermid | ReutersThe Food and Drug [...]
Ro to offer weight loss drug Zepbound vials by working with Eli Lilly
Patients will be able to access Zepbound single-dose vials at RoCoutesy: RoDirect-to-consumer health-care startup Ro on Wednesday said its platform wi [...]
Eli Lilly Zepbound causes more weight loss than Novo Nordisk Wegovy: Trial
A combination image shows an injection pen of Zepbound, Eli Lilly's weight loss drug, and boxes of Wegovy, made by Novo Nordisk. ReutersEli Lilly on W [...]
Eli Lilly (LLY) earnings Q3 2024
Lilly Biotechnology Center is shown in San Diego, California, U.S. March 1, 2023.Mike Blake | ReutersEli Lilly on Wednesday fell short of profit and r [...]
Eli Lilly to build $4.5 billion research and manufacturing center
Eli Lilly will spend $4.5 billion to build a center aimed at finding better ways to manufacture its medicines. The facility, called the Lilly Medicine [...]
Eli Lilly releases new, cheaper form of weight loss drug
Eli Lilly on Tuesday released a new form of its weight loss drug Zepbound for roughly half its usual monthly list price to reach millions of patients [...]
Eli Lilly weight loss drug cuts risk of developing diabetes in trial
Eli Lilly's highly popular weight loss drug reduced the risk of developing Type 2 diabetes by 94% in obese or overweight adults with prediabetes compa [...]
Eli Lilly (LLY) earnings Q2 2024
Eli Lilly on Thursday reported second-quarter earnings and revenue that blew past expectations and hiked its full-year revenue outlook by $3 billion a [...]
Eli Lilly Zepbound, Mounjaro available after shortages, FDA says
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023.Brendan McDermid | ReutersAll doses of Eli [...]
Eli Lilly weight loss drug Zepbound cuts heart failure risks in study
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March 28, 2024. Shelby Knowles | Bloomber [...]
FDA approves Eli Lilly Alzheimer’s drug donanemab
A sign with the company logo sits outside of the headquarters campus of Eli Lilly and Company on March 17, 2024 in Indianapolis, Indiana.Scott Olson | [...]
Eli Lilly expects FDA call on Zepbound for sleep apnea in near term
Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the treatment of the most common sleep-related breathing di [...]
Eli Lilly CFO Anat Ashkenazi on managing soaring demand for GLP-1s
A pharmacist holds boxs of Eli Lilly & Co. Mounjaro brand tirzepatide medication arranged at a pharmacy in Provo, Utah, US, on Monday, Nov. 27, 20 [...]
FDA advisors recommend Eli Lilly Alzheimer’s drug donanemab
Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly & Co.'s shares climbed in early US trading after its exp [...]